Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.021x
Based on the latest financial reports, Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a cash flow conversion efficiency ratio of 0.021x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.00 Million) by net assets (CN¥4.13 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guangdong Zhongsheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Guangdong Zhongsheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Guangdong Zhongsheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Zhongsheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nanning Chemical Industry Co Ltd
SHG:600301
|
0.065x |
|
Pearl Abyss Corp
KQ:263750
|
0.017x |
|
Flat Glass Group Co. Ltd
PINK:FGSGF
|
0.040x |
|
LuxNet
TWO:4979
|
0.097x |
|
Shenyang Machine Tool Co Ltd
SHE:000410
|
0.062x |
|
Minmetals Capital Co Ltd
SHG:600390
|
0.064x |
|
A10 Network
NYSE:ATEN
|
0.107x |
|
Societatea Nationala de Transport Gaze Naturale Transgaz SA
RO:TGN
|
0.016x |
Annual Cash Flow Conversion Efficiency for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.01 Billion | CN¥337.84 Million | 0.084x | +100.03% |
| 2023-12-31 | CN¥4.53 Billion | CN¥190.61 Million | 0.042x | +154.87% |
| 2022-12-31 | CN¥3.82 Billion | CN¥63.07 Million | 0.017x | -90.61% |
| 2021-12-31 | CN¥3.54 Billion | CN¥622.77 Million | 0.176x | +359.44% |
| 2020-12-31 | CN¥3.63 Billion | CN¥138.93 Million | 0.038x | -36.93% |
| 2019-12-31 | CN¥4.13 Billion | CN¥251.16 Million | 0.061x | -26.56% |
| 2018-12-31 | CN¥3.95 Billion | CN¥326.78 Million | 0.083x | -16.59% |
| 2017-12-31 | CN¥3.73 Billion | CN¥369.91 Million | 0.099x | +0.37% |
| 2016-12-31 | CN¥3.42 Billion | CN¥338.28 Million | 0.099x | +8.41% |
| 2015-12-31 | CN¥2.11 Billion | CN¥192.25 Million | 0.091x | +72.01% |
| 2014-12-31 | CN¥1.90 Billion | CN¥100.60 Million | 0.053x | -16.77% |
| 2013-12-31 | CN¥1.74 Billion | CN¥110.95 Million | 0.064x | -29.06% |
| 2012-12-31 | CN¥1.59 Billion | CN¥142.38 Million | 0.090x | +87.87% |
| 2011-12-31 | CN¥1.48 Billion | CN¥70.56 Million | 0.048x | -27.79% |
| 2010-12-31 | CN¥1.39 Billion | CN¥91.72 Million | 0.066x | -15.09% |
| 2009-12-31 | CN¥1.30 Billion | CN¥100.89 Million | 0.078x | -81.57% |
| 2008-12-31 | CN¥172.40 Million | CN¥72.86 Million | 0.423x | +11.80% |
| 2007-12-31 | CN¥130.56 Million | CN¥49.35 Million | 0.378x | +192.84% |
| 2006-12-31 | CN¥138.72 Million | CN¥17.91 Million | 0.129x | -- |